Abstract
82 Implementing the neoadjuvant chemotherapy+Nivolumab pathway for patients with resectable Non-Small Cell Lung Cancer (NSCLC)- A single UK center experience (UHNM-Stoke On Trent)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
